Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
POLYVAC (Center for Research and Production of Vaccines and Biologicals) is a leading Vietnamese state-owned vaccine manufacturer and research center under the Ministry of Health. Established in 1994, the institute specializes in the development and large-scale production of essential vaccines, including those for measles, rubella, and poliomyelitis. POLYVAC operates high-standard manufacturing facilities that comply with WHO-GMP standards and plays a critical role in Vietnam's National Expanded Program on Immunization (EPI). Beyond production, the institute engages in research and development of new biological products and collaborates with international organizations like JICA and WHO to enhance vaccine technology. Its efforts have made Vietnam one of the few developing countries capable of self-sufficient vaccine production for several major infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polyvac Institute.